CASI PHARMACEUTICALS, INC. (CASIF) Gross profit 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual gross profit history from SEC filings — each fiscal year as reported.
$10.1MFY2025 · since FY2020: $5.6M → $10.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.1M | -9.6% |
| FY2024 | $11.1M | -44.4% |
| FY2023 | $20.1M | -26.5% |
| FY2022 | $27.3M | +54.9% |
| FY2021 | $17.6M | +212.6% |
| FY2020 | $5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Net marginCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Free cash flowCASIF Capital expendituresCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →